<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36649947</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>19</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>22</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1488-2329</ISSN><JournalIssue CitedMedium="Internet"><Volume>195</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Jan</Month><Day>17</Day></PubDate></JournalIssue><Title>CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne</Title><ISOAbbreviation>CMAJ</ISOAbbreviation></Journal><ArticleTitle>Treating common and potentially modifiable symptoms of post-COVID-19 condition (long COVID) in adults.</ArticleTitle><Pagination><StartPage>E80</StartPage><EndPage>E81</EndPage><MedlinePgn>E80-E81</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1503/cmaj.220824</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Quinn</LastName><ForeName>Kieran L</ForeName><Initials>KL</Initials><AffiliationInfo><Affiliation>Department of Medicine and Institute of Health Policy, Management, and Evaluation (Quinn, Razak, Cheung), University of Toronto; ICES Central (Quinn); Department of Medicine (Quinn, Cheung), Sinai Health System and University Health Network; Temmy Latner Centre for Palliative Care (Quinn); Department of Medicine (Razak), Li Ka Shing Knowledge Institute, Unity Health Toronto; Department of Medicine (Razak), St. Michael's Hospital, Unity Health Toronto; Toronto General Hospital Research Institute and Schroeder Arthritic Institute (Cheung), University Health Network, Toronto, Ont. kieran.quinn@sinaihealth.ca.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheung</LastName><ForeName>Angela M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Department of Medicine and Institute of Health Policy, Management, and Evaluation (Quinn, Razak, Cheung), University of Toronto; ICES Central (Quinn); Department of Medicine (Quinn, Cheung), Sinai Health System and University Health Network; Temmy Latner Centre for Palliative Care (Quinn); Department of Medicine (Razak), Li Ka Shing Knowledge Institute, Unity Health Toronto; Department of Medicine (Razak), St. Michael's Hospital, Unity Health Toronto; Toronto General Hospital Research Institute and Schroeder Arthritic Institute (Cheung), University Health Network, Toronto, Ont.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Razak</LastName><ForeName>Fahad</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Medicine and Institute of Health Policy, Management, and Evaluation (Quinn, Razak, Cheung), University of Toronto; ICES Central (Quinn); Department of Medicine (Quinn, Cheung), Sinai Health System and University Health Network; Temmy Latner Centre for Palliative Care (Quinn); Department of Medicine (Razak), Li Ka Shing Knowledge Institute, Unity Health Toronto; Department of Medicine (Razak), St. Michael's Hospital, Unity Health Toronto; Toronto General Hospital Research Institute and Schroeder Arthritic Institute (Cheung), University Health Network, Toronto, Ont.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>CMAJ</MedlineTA><NlmUniqueID>9711805</NlmUniqueID><ISSNLinking>0820-3946</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>CMAJ. 2023 Feb 21;195(7):E276. doi: 10.1503/cmaj.230115</RefSource><PMID Version="1">36810225</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Competing interests: Kieran Quinn is a former assistant scientific director of the Ontario COVID-19 Science Advisory Table from Aug. 8, 2022, to Sept. 30, 2022. He is the current assistant scientific director of the Ontario Public Health Emergencies Science Advisory Committee and has received Canadian Institutes of Health Research (CIHR) grants (awarded to his institution) to study the long-term effects of COVID-19. He has served as an advisor for the chief science advisor of the Canada Task Force on Post-COVID-19 Condition. Fahad Razak holds a salary award as the Graham Farquharson knowledge translation fellow from the PSI Foundation and is an employee of Ontario Health. He was also an employee of Public Health Ontario during the writing of this manuscript. Fahad Razak has received grants (outside the current article) to study COVID-19 from the CIHR, Canadian Frailty Network, University of Toronto (including the Department of Medicine, St. Michael&#x2019;s Hospital and the Sunnybrook Health Sciences Centre), Digital Research Alliance of Canada (Data Champions Pilot Project) and Royal College of Physicians and Surgeons of Canada. Angela Cheung has received CIHR grants (awarded to her institution) for CANCOV (platform observational study of COVID-19 in Canada) and RECLAIM (adaptive platform randomized controlled trials for long COVID interventions). MediciNova is providing a study drug and placebo for the RECLAIM trial, a multicentre study across Canada. Angela Cheung has served as an advisor for the Ontario COVID-19 Science Advisory Table, Public Health Agency of Canada, Canadian Agency for Drugs and Technologies in Health, COVID-19 Immunity Task Force and chief science advisor of the Canada Task Force on Post-COVID-19 Condition. No other competing interests were declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>17</Day><Hour>20</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36649947</ArticleId><ArticleId IdType="pmc">PMC9851632</ArticleId><ArticleId IdType="doi">10.1503/cmaj.220824</ArticleId><ArticleId IdType="pii">195/2/E80</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Herrera JE, Niehaus WN, Whiteson J, et al. . Multidisciplinary collaborative consensus guidance statement on the assessment and treatment of fatigue in postacute sequelae of SARS-CoV-2 infection (PASC) patients. PM R. 2021;13:1027&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8441628</ArticleId><ArticleId IdType="pubmed">34346558</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H, Raza S, Nowell J, et al. . Long COVID &#x2014; mechanisms, risk factors, and management. BMJ 2021;374:n1648.</Citation><ArticleIdList><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouteleux B, Henrot P, Ernst R, et al. . Respiratory rehabilitation for COVID-19 related persistent dyspnoea: a one-year experience. Respir Med 202;189:106648.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8511554</ArticleId><ArticleId IdType="pubmed">34689061</ArticleId></ArticleIdList></Reference><Reference><Citation>Sateia MJ, Buysse DJ, Krystal AD, et al. . Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med 2017;13:307&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5263087</ArticleId><ArticleId IdType="pubmed">27998379</ArticleId></ArticleIdList></Reference><Reference><Citation>Raj SR, Guzman JC, Harvey P, et al. . Canadian Cardiovascular Society Position Statement on postural orthostatic tachycardia syndrome (POTS) and related disorders of chronic orthostatic intolerance. Can J Cardiol 2020;36:357&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">32145864</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>